140 related articles for article (PubMed ID: 24236585)
1. The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches.
Dickson RP; Huang YJ; Martinez FJ; Huffnagle GB
Am J Respir Crit Care Med; 2013 Nov; 188(10):1185-6. PubMed ID: 24236585
[No Abstract] [Full Text] [Related]
2. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
4. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
5. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
6. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H
Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581
[TBL] [Abstract][Full Text] [Related]
7. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
8. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.
Leitao Filho FS; Alotaibi NM; Ngan D; Tam S; Yang J; Hollander Z; Chen V; FitzGerald JM; Nislow C; Leung JM; Man SFP; Sin DD
Am J Respir Crit Care Med; 2019 May; 199(10):1205-1213. PubMed ID: 30376356
[No Abstract] [Full Text] [Related]
9. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
[TBL] [Abstract][Full Text] [Related]
10. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
11. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
13. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
[TBL] [Abstract][Full Text] [Related]
14. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B
Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869
[TBL] [Abstract][Full Text] [Related]
15. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
Xiao W; Du LY; Mao B; Miao TW; Fu JJ
BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
[TBL] [Abstract][Full Text] [Related]
16. Sputum Microbiome Dynamics in Chronic Obstructive Pulmonary Disease Patients during an Exacerbation Event and Post-Stabilization.
López Caro JC; Santibáñez M; García Rivero JL; Villanueva M; Sainz J; González Astorqui P; Hierro M; Rodríguez Porres M; Paras Bravo P; Mira A; Rodriguez JC; Galiana A;
Respiration; 2019; 98(5):447-454. PubMed ID: 31437842
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
18. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
[TBL] [Abstract][Full Text] [Related]
19. Chance favors the prepared mind.
Sethi S
Am J Respir Crit Care Med; 2012 Dec; 186(11):1070-1. PubMed ID: 23204370
[No Abstract] [Full Text] [Related]
20. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]